Ben is joint lead for ZS’s Trial Launch Catalyst (TLC)TM, a suite of capabilities helping sponsors across the industry to accelerate trials through better engagement with sites and patients.
Ben’s expertise lies in the interface between R&D and commercial functions in life science companies. He employs years of experience in commercial strategy, market research and marketing, looking at clinical trial design and execution from a different lens. To this end, Ben has worked extensively in trial engagement strategy, positioning and value proposition design, and voice-of-the-site research.
Prior to joining ZS, Ben worked in a boutique consultancy company with a focus on emerging biotechs.
Ben earned an bachelor’s degree and master’s degree in natural sciences from the University of Cambridge.